Clinical Trial Update: Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application

View source ↗

Summary

Clinical trial update evaluating GORE SYNECOR Biomaterial for ventral and incisional hernias, with attention to focused patient populations and long-term applic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Incisional Hernia
• Ventral Hernia

Drugs mentioned

• GORE SYNECOR Biomaterial

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Hernia, Ventral, Hernia Incisional | Status: ACTIVE_NOT_RECRUITING